Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPension (IS)Preferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bruker (BRKR) Long-Term Debt Repayments (2018 - 2026)

Bruker filings provide 13 years of Long-Term Debt Repayments readings, the most recent being $145.2 million for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 1810.53% to $145.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $423.3 million, a 212.63% increase, with the full-year FY2025 number at $466.5 million, up 244.53% from a year prior.
  • Long-Term Debt Repayments hit $145.2 million in Q4 2025 for Bruker, down from $255.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $488.3 million in Q4 2021 to a low of $400000.0 in Q1 2021.
  • Median Long-Term Debt Repayments over the past 4 years was $9.8 million (2024), compared with a mean of $80.9 million.
  • Biggest five-year swings in Long-Term Debt Repayments: soared 5004.76% in 2024 and later tumbled 92.82% in 2025.
  • Bruker's Long-Term Debt Repayments stood at $488.3 million in 2021, then plummeted by 99.57% to $2.1 million in 2023, then soared by 261.9% to $7.6 million in 2024, then surged by 1810.53% to $145.2 million in 2025.
  • The last three reported values for Long-Term Debt Repayments were $145.2 million (Q4 2025), $255.8 million (Q3 2025), and $14.6 million (Q2 2025) per Business Quant data.